JPWO2020165425A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020165425A5
JPWO2020165425A5 JP2021546007A JP2021546007A JPWO2020165425A5 JP WO2020165425 A5 JPWO2020165425 A5 JP WO2020165425A5 JP 2021546007 A JP2021546007 A JP 2021546007A JP 2021546007 A JP2021546007 A JP 2021546007A JP WO2020165425 A5 JPWO2020165425 A5 JP WO2020165425A5
Authority
JP
Japan
Prior art keywords
peptide
conjugate
spytag
partner
coupling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021546007A
Other languages
Japanese (ja)
Other versions
JP2022520550A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/053933 external-priority patent/WO2020165425A1/en
Publication of JP2022520550A publication Critical patent/JP2022520550A/en
Publication of JPWO2020165425A5 publication Critical patent/JPWO2020165425A5/ja
Pending legal-status Critical Current

Links

Claims (13)

カップリングペプチドとパートナーペプチドとの間の共有イソペプチド結合を介してパートナーペプチドにカップリングするカップリングペプチドを含む封入体を含む複合であって、当該カップリングペプチドが、連結システムを構成する2つのペプチドの1つをk委細し、かつ当該カップリングペプチドが、パートナーペプチドに結合する機能を有するアミノ酸のポリマーである、複合体2. A complex comprising an inclusion body comprising a coupling peptide coupled to a partner peptide via a covalent isopeptide bond between the coupling peptide and the partner peptide , the coupling peptide constituting the linkage system. a conjugate that is a polymer of amino acids that binds one of the two peptides and the coupling peptide has the function of binding to a partner peptide. 前記カップリングペプチドが、前記イソペプチド結合に含まれる1つの残基を含み、そして前記パートナーペプチドが、前記イソペプチドに含まれる他の前記を含む、請求項1に記載の複合体。 2. The conjugate of claim 1, wherein said coupling peptide comprises one residue involved in said isopeptide bond and said partner peptide comprises the other residue involved in said isopeptide. 前記カップリングぺプチド及びパートナーペプチドが、グラム陽性又はグラム陰性細菌のタンパク質に由来する、請求項1~2のいずれか1項に記載の複合体。 The conjugate of any one of claims 1-2, wherein the coupling peptide and partner peptide are derived from Gram-positive or Gram-negative bacterial proteins. 前記カップリングペプチドが、SpyTag、KTag、SnoopTag、SpyTag002、SpyTag003、SpyTag0128、SdyTag、DogTag、SnoopTagJr、及びBDTagから成る群から選択される、請求項1~3のいずれか1項に記載の複合体。 The conjugate of any one of claims 1-3, wherein the coupling peptide is selected from the group consisting of SpyTag, KTag, SnoopTag, SpyTag002, SpyTag003, SpyTag0128, SdyTag, DogTag, SnoopTagJr, and BDTag. 前記パートナーペプチドが、SpyTag、KTag、SpyCatcher、SnoopCatcher、SpyCatcher002、SpyCatcher003、SpyCatcher0128、SdyCatcher、DogTag、SnoopTagJr、及びBDTagから成る群から選択される、請求項1~4のいずれか1項に記載の複合体。 The conjugate of any one of claims 1-4, wherein the partner peptide is selected from the group consisting of SpyTag, KTag, SpyCatcher, SnoopCatcher, SpyCatcher002, SpyCatcher003, SpyCatcher0128, SdyCatcher, DogTag, SnoopTagJr, and BDTag. . 前記カップリングペプチド及びパートナーペプチドが、SpyTag-SpyCatcher、SpyTag-SpyCatcher002、SnoopTag-SnoopCatcher、SpyTag002-SpyCatcher002、SpyTag002-SpyCatcher、SpyTag003-SpyCatcher003、SpyTag0128-SpyCatcher0128、SdyTag-SdyCatcher、KTag-SpyTag、SpyTag-KTag、DogTag-SnoopTagJr、SnoopTagJr-DogTag、SpyTag-BDTag及びBDTag-SpyTagから成る群から選択された連結ペアを形成する、請求項1~3のいずれか1項に記載の複合体。 前記カップリングペプチド及びパートナーペプチドが、SpyTag-SpyCatcher、SpyTag-SpyCatcher002、SnoopTag-SnoopCatcher、SpyTag002-SpyCatcher002、SpyTag002-SpyCatcher、SpyTag003-SpyCatcher003、SpyTag0128-SpyCatcher0128、SdyTag-SdyCatcher、KTag-SpyTag、SpyTag-KTag、DogTag - a conjugate according to any one of claims 1 to 3, which forms a linked pair selected from the group consisting of SnoopTagJr, SnoopTagJr-DogTag, SpyTag-BDTag and BDTag-SpyTag. 少なくとも1つの目的のタンパク質(PDI)又はその一部をさらに含む、請求項1~のいずれか1項に記載の複合体。 A conjugate according to any one of claims 1 to 6 , further comprising at least one protein of interest (PDI) or part thereof. 前記目的のタンパク質又はその一部が、抗原又はそのフラグメントである、請求項に記載の複合体。 8. The conjugate of claim 7 , wherein said protein of interest or portion thereof is an antigen or fragment thereof. 前記封入体が、封入体形成配列をさらに含む、請求項1~8のいずれか1項に記載の複合体。 The complex of any one of claims 1-8 , wherein said inclusion body further comprises an inclusion body forming sequence. 前記パートナーペプチドが、標的部分等の追加の部分を含む、請求項1~9のいずれか1項に記載の複合体。 A conjugate according to any one of claims 1 to 9 , wherein said partner peptide comprises additional moieties such as targeting moieties . 請求項1~1のいずれか1項に記載の複合体を含む組成物。 A composition comprising a conjugate according to any one of claims 1-10 . 診断、予後、予防又は治療剤として使用するための、請求項1~1のいずれか1項に記載の複合体又は請求項11に記載の組成物。 A conjugate according to any one of claims 1 to 10 or a composition according to claim 11 for use as a diagnostic, prognostic, prophylactic or therapeutic agent. 請求項1~10のいずれか1項に記載の複合体の生成方法であって、カップリングペプチドを含む封入体を、カップリングペプチドとパートナーペプチドとの間の共有イソペプチド結合を介してパートナーペプチドにコンジュゲートし、それにより、前記複合体を形成する工程を含む方法。 11. A method of producing a conjugate according to any one of claims 1-10 , wherein an inclusion body containing a coupling peptide is bound to a partner peptide via a covalent isopeptide bond between the coupling peptide and the partner peptide. to thereby form said complex.
JP2021546007A 2019-02-15 2020-02-14 Decorative inclusion bodies and their use Pending JP2022520550A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19157490 2019-02-15
EP19157490.4 2019-02-15
PCT/EP2020/053933 WO2020165425A1 (en) 2019-02-15 2020-02-14 Decorated inclusion body and uses thereof

Publications (2)

Publication Number Publication Date
JP2022520550A JP2022520550A (en) 2022-03-31
JPWO2020165425A5 true JPWO2020165425A5 (en) 2023-02-16

Family

ID=65686666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021546007A Pending JP2022520550A (en) 2019-02-15 2020-02-14 Decorative inclusion bodies and their use

Country Status (7)

Country Link
US (1) US20220064691A1 (en)
EP (1) EP3923968A1 (en)
JP (1) JP2022520550A (en)
CN (1) CN113347988A (en)
AU (1) AU2020220637A1 (en)
CA (1) CA3130159A1 (en)
WO (1) WO2020165425A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112062856A (en) * 2020-09-16 2020-12-11 华侨大学 Preparation method of magnetic carrier for covalently capturing target protein
WO2023052600A1 (en) * 2021-09-30 2023-04-06 Adaptvac Aps Methods and particles for modulating an immune response
CN117264081A (en) * 2023-11-21 2023-12-22 华南理工大学 Dipeptide receptor agonist and preparation method and application thereof
CN117866110B (en) * 2023-12-27 2024-06-11 广东唯泰生物科技有限公司 Fourth generation chimeric antigen receptor targeting FLT-3 and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578308A (en) 1990-02-12 1996-11-26 Capiau; Carine Glutaraldehyde and formalin detoxified bordetella toxin vaccine
GB201002362D0 (en) 2010-02-11 2010-03-31 Isis Innovation Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
CA2885333C (en) 2012-09-26 2021-02-09 Fvg Limited Subunit immersion vaccines for fish
US11124555B2 (en) * 2017-01-27 2021-09-21 Abera Bioscience Ab Fusion polypeptides comprising one or more inclusion body tags, methods and uses
WO2018162450A1 (en) * 2017-03-06 2018-09-13 Fundación Para La Investigación Médica Aplicada New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells

Similar Documents

Publication Publication Date Title
JP2022065174A5 (en)
Kipriyanov et al. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment–core streptavidin fusion
JP2019514361A5 (en)
JP2019521643A5 (en)
JP2004523205A5 (en)
JP2017509594A5 (en)
WO2018230257A1 (en) IgG-BINDING PEPTIDE, AND SPECIFIC MODIFICATION OF ANTIBODY WITH SAID PEPTIDE
JP3280376B2 (en) Multivalent antigen binding protein
WO2003046560B1 (en) Self-assembly molecules
RU2013154489A (en) IMMUNOGENIC COMPOSITION OF PRESENTATION OF MULTIPLE ANTIGENS RELATING TO HER METHODS AND APPLICATION
WO2003070760A3 (en) Anti-amyloid beta antibodies and their use
JP2016511279A5 (en)
NZ596865A (en) Single-chain multivalent binding proteins with effector function
JP2018537415A5 (en)
JP2020515280A5 (en)
JP2009500298A5 (en)
JP2017002039A (en) Novel polyfunctional compound for pharmaceutical purpose
BRPI0816103A2 (en) method for binding proteins to chargers by making use of tamavidins.
KR20210018205A (en) Antigenic OspA polypeptide
JP2020506685A5 (en)
JP2020526497A5 (en)
JP2971067B2 (en) Fibronectin binding protein and its preparation
JPWO2020165425A5 (en)
WO2017082213A1 (en) SEPARATING AGENT FOR HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES, AND METHOD FOR SEPARATING HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES USING SAME
JP2004524023A5 (en)